.jpg)
Clinical Trials Market, Size, Share, Outlook and Opportunities 2020- 2026
- ID:OGAHM1960928
- Published: September-2021
- Pages:130
- OGAnalysis
Global Clinical Trials Market Size, share, Outlook and Growth Opportunities to 2026: By Phase (Phase I, Phase II, Phase III, and Phase IV), By Design (Interventional, Expanded Access and Observational) and By Region
Key Findings
- Clinical Trials Market is set to showcase CAGR of 5.21% in the forecasted period 2020-2026.
- Prevalence of carcinogenic diseases paves strong clinical trial market growth.
- Strong R&D funds, pipeline of clinical trials shape the market size across medical-driven countries.
- Huge investments, pipeline of clinical trials and collaborative approaches strengthen key players’ market share.
Growing demand for new medical equipments and medicines coupled with rising investment on R&D activities for development of effective medicines are key driving factors propelling the growth of global clinical trials market.
Top pharmaceutical companies are increasing the R&D intensity for rapid drug development along with clinical trials to deliver precision medicine and therapeutic drug for high risk diseases. For instance, funding statistics of global pharmaceutical companies estimate 9.9 billion U.S. dollars spending by Johnson & Johnson.
The clinical trial market continues to showcase potential market growth across Americas and EU countries with increasing drug developments and strong clinical trial supplies across the regions. However, escalating regulatory requirements and approval timelines have shifted the focus of companies to developing markets.
Geographical distribution of clinical trials is gradually shifting from emerged countries to developing countries. The difficulty in patient recruitment and increasing cost of clinical trials has led many biopharmaceutical companies to shift towards regions such Asia Pacific, South America, and Middle East for quick patient recruitment and cost efficiency.
The ongoing attempts of globalizing clinical research by key players in emerging markets such as China, Eastern Europe, Turkey, Argentina and Brazil play a critical role in advancing clinical trials market.
Global Clinical Trials Market Insights
The 2020 series of global market size, share, outlook, trends and growth prospects is a comprehensive analysis on global Clinical Trials market conditions. Major trends shaping the near and long term future of the industry, opportunities, drivers and restraints of Clinical Trials market, detailed porter’s five forces analysis and competitive insights are included in the research report.
Global Clinical Trials Market Share by Phase
The report presents the detailed annual outlook of each phase of the Clinical Trials market to 2026. The report studied 4 phases including Phase I, Phase II, Phase III, and Phase IV. Of these phases, phase III is estimated to occupy major share in the global industry.
Global Clinical Trials Market Analysis by Design
The report provides detailed Clinical Trials market analysis by various designs including interventional, expanded access and observational. Among these designs, interventional segment is analysed to dominate the industry growth in future.
Global Clinical Trials Market Revenue by Region
The current Clinical Trials market size in terms of revenue across 5 regions including North America, Europe, Asia Pacific, South & Central America and Middle East & Africa are studied in the report. In addition, historic data from 2017 and annual forecasts to 2026 are also included in the research report. Globally, North America is the major market for Clinical Trials.
Global Clinical Trials Market Analysis by Company
Top 10 leading companies in global Clinical Trials market are analyzed in the report along with their business overview, operations, geographical locations, financial analysis, SWOT profile and Clinical Trials products & services.
Global Clinical Trials Market News and Recent Developments
Latest news and industry developments in terms of Clinical Trials product launches, acquisitions, organic & inorganic growth strategies, joint ventures and collaborations, product launches, market expansions etc are included in the report.
Scope:
Long term perspective on the Clinical Trials industry: 2019 (base year), 2020- 2026 (forecast period)
Clinical Trials Market- Forecasts by Segments- Phase and Design by geography.
- The research work categorizes the global Clinical Trials market based on phase into 4 categories including Phase I, Phase II, Phase III, and Phase IV.
- It provides the market outlook by 3 designs including interventional, expanded access and observational.
- Clinical Trials market across countries in 5 regions including North America, Europe, Asia-Pacific, South & Central America and Middle East & Africa are covered.
Clinical Trials Market- Strategic Analysis Review
- Key strategies opted by leading players
- Short to Long Term Industry Trends
- Porter’s Five Forces Analysis
- Supply side and Demand Side Drivers and Challenges
Clinical Trials Market- Growth Opportunities
- Potential New Business Opportunities
- Key Areas of Focus in forecast period
Clinical Trials Market- Competitive Scenario
- 10 companies are analysed in the report including Johnson & Johnson, Clinipace, Laboratory Corporation of America, Eli Lilly and Company, ICON PLC, Novo Nordisk AS, PAREXEL International Corporation, Pfizer Inc., Pharmaceutical Product Development LLC, and F. Hoffmann-La Roche Ltd.
- Company Peer-to-Peer Comparison
- Company Profile and SWOT Analysis
- Financial Analysis
Table of Contents
1. Table of Contents
1.1 List of Tables
1.2 List of Figures
2. Introduction to Global Clinical Trials Market
2.1 Global Clinical Trials Market Snapshot, 2019
2.2 Clinical Trials Industry Overview
2.3 Research Perspective
3. Global Clinical Trials Market- Strategic Analysis
3.1 Short Term and Long Term Industry Trends Affecting Global Clinical Trials Market
3.2 Leading Clinical Trials Types Targeted by Global Manufacturers
3.3 Key Consumption Patterns of Clinical Trials
3.4 Potential Markets Vital for business Expansion
3.5 Five Forces Analysis
3.6 Drivers and Restraints
4. Global Clinical Trials Market Outlook and Growth Opportunities by Phase
4.1 Phase I Clinical Trials Market Outlook, 2020- 2026
4.2 Phase II Clinical Trials Market Outlook, 2020- 2026
4.3 Phase III Clinical Trials Market Outlook, 2020- 2026
4.4 Phase IV Clinical Trials Market Outlook, 2020- 2026
5. Global Clinical Trials Market Outlook and Growth Opportunities by Design
5.1 Clinical Trials Market Outlook by Interventional Design, 2020- 2026
5.2 Clinical Trials Market Outlook by Expanded Access Design, 2020- 2026
5.3 Clinical Trials Market Outlook by Observational Design, 2020- 2026
6. Asia Pacific Clinical Trials Market Outlook and Growth Opportunities
6.1 Key Findings, 2019
6.2 Asia Pacific Clinical Trials Market Outlook by Phase, 2020- 2026
6.3 Asia Pacific Clinical Trials Market Outlook by Design, 2020- 2026
6.4 Asia Pacific Clinical Trials Market Outlook by Country, 2020- 2026
7. Europe Clinical Trials Market Outlook and Growth Opportunities
7.1 Key Findings, 2019
7.2 Europe Clinical Trials Market Outlook by Phase, 2020- 2026
7.3 Europe Clinical Trials Market Outlook by Design, 2020- 2026
7.4 Europe Clinical Trials Market Outlook by Country, 2020- 2026
8. North America Clinical Trials Market Outlook and Growth Opportunities
8.1 Key Findings, 2019
8.2 North America Clinical Trials Market Outlook by Phase, 2020- 2026
8.3 North America Clinical Trials Market Outlook by Design, 2020- 2026
8.4 North America Clinical Trials Market Outlook by Country, 2020- 2026
9. South & Central America Clinical Trials Market Outlook and Growth Opportunities
9.1 Key Findings, 2019
9.2 South & Central America Clinical Trials Market Outlook by Phase, 2020- 2026
9.3 South & Central America Clinical Trials Market Outlook by Design, 2020- 2026
9.4 South & Central America Clinical Trials Market Outlook by Country, 2020- 2026
10. Middle East & Africa Clinical Trials Market Outlook and Growth Opportunities
10.1 Key Findings, 2019
10.2 Middle East & Africa Clinical Trials Market Outlook by Phase, 2020- 2026
10.3 Middle East & Africa Clinical Trials Market Outlook by Design, 2020- 2026
10.4 Middle East & Africa Clinical Trials Market Outlook by Country, 2020- 2026
11. Competitive Landscape
11.1 Leading Players (Company Profile, SWOT Analysis, Clinical Trials Products, Financial Analysis)
11.1.1 Johnson & Johnson
11.1.2 Clinipace
11.1.3 Laboratory Corporation of America
11.1.4 Eli Lilly and Company
11.1.5 ICON PLC
11.1.6 Novo Nordisk AS
11.1.7 PAREXEL International Corporation
11.1.8 Pfizer Inc.
11.1.9 Pharmaceutical Product Development LLC
11.1.10 F. Hoffmann-La Roche Ltd
11.2 Company Benchmarking
11.3 Financial Analysis
12. Recent News and Deals Landscape
12.1 Mergers and Acquisitions
12.2 New Product Launches
12.3 Asset Transactions
12.4 Financial Announcements
13. Appendix
13.1 OGAnalysis Expertise
13.2 Sources and Research Methodology
13.3 Contact Information
| Type | Delivery Format | Details |
|---|---|---|
| Hard Copy | A printed copy of the report will be shipped to you. | |
| CD-ROM | The report will be shipped to you in CD ROM format. | |
| SINGLE USER Electronic (PDF) | The report will be delivered to your email address in PDF format. | The license allows one specific user access to the product. |
| SITE LICENSE Electronic (PDF) | The report will be delivered to your email address in PDF format. | The license allows all users within a given geographical location of your organization access to the product. |
| ENTERPRISEWIDE Electronic (PDF) | The report will be delivered to your email address in PDF format. | The license allows all employees within your organization in different geographic locations access to the product. |
| 1 - 5 USERS Electronic (PDF) | The report will be delivered to your email address in PDF format. | The license allows up to five users have access to the product. |
| 1 – 10 USERS Electronic (PDF) | The report will be delivered to your email address in PDF format. | The license allows up to ten users have access to the product. |
| 1 – 15 USERS Electronic (PDF) | The report will be delivered to your email address in PDF format. | The license allows up to fifteen users have access to the product. |
| 1 - 5 USERS Online Access (For Databases) | Database is accessed online through a secure website. You will receive a username and password via email to access to the online directory. | The license allows up to five users have access to the product. |
| 1 - 10 USERS Online Access(For Databases) | Database is accessed online through a secure website. You will receive a username and password via email to access to the online directory. | The license allows up to ten users have access to the product. |
| 1 - 15 USERS Online Access(For Databases) | Database is accessed online through a secure website. You will receive a username and password via email to access to the online directory. | The license allows up to fifteen users have access to the product. |
| 1 - 5 USERS Electronic (Excel) | The Excel spreadsheet will be emailed to you. | The license allows up to five users have access to the product. |
